{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:24:28Z","timestamp":1791559468818,"version":"4.3.4"},"reference-count":36,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["acrjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Arthritis &amp; Rheumatology"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess long\u2010term efficacy and safety of guselkumab, an interleukin\u201023 p19 subunit (IL\u201023p19) inhibitor, in patients with active psoriatic arthritis (PsA) from the phase III DISCOVER\u20102 trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In the DISCOVER\u20102 trial, patients with active PsA (\u22655 swollen joints and\u2009\u22655 tender joints; C\u2010reactive protein level\u2009\u22650.6 mg\/dl) despite prior nonbiologic therapy were randomized to receive the following: guselkumab 100 mg every 4\u2009weeks; guselkumab 100 mg at weeks 0 and 4 and then every 8\u2009weeks; or placebo with crossover to guselkumab 100 mg every 4\u2009weeks, beginning at week 24. Efficacy assessments included American College of Rheumatology \u226520%\/50%\/70% improvement criteria (ACR20\/50\/70), Investigator\u2019s Global Assessment (IGA) of psoriasis score of 0 (indicating complete skin clearance), resolution of enthesitis (Leeds Enthesitis Index) and dactylitis (Dactylitis Severity Score), and changes in the Sharp\/van der Heijde modified radiographic scores for PsA. Clinical data (imputed as no response\/no change from baseline if missing) and observed radiographic data were summarized through week 100; safety assessments continued through week 112.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 739 randomized and treated patients, 652 (88%) completed treatment through week 100. Across groups of guselkumab\u2010treated patients (including those in the placebo\u2013guselkumab crossover group), the following findings at week 100 indicated that amelioration of arthritis signs\/symptoms and extraarticular manifestations was durable through 2\u2009years: ACR20 response (68\u201376%), ACR50 response (48\u201356%), ACR70 response (30\u201336%), IGA score of 0 (55\u201367%), enthesitis resolution (62\u201370%), and dactylitis resolution (72\u201383%). Mean changes in the Sharp\/van der Heijde modified score for PsA from weeks 52 to week 100 (range 0.13\u20130.75) indicated that the low rates of radiographic progression observed among guselkumab\u2010treated patients at earlier time points extended through week 100. Through week 112, 8% (5.8 per 100 patient\u2010years) and 3% (1.9 per 100 patient\u2010years) of the 731 guselkumab\u2010treated patients had a serious adverse event or serious infection, respectively; 1 death occurred (road traffic accident).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In biologic\u2010naive PsA patients, guselkumab provided durable improvements in multiple disease domains with no unexpected safety findings through 2\u2009years.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/art.42010","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T05:01:10Z","timestamp":1635742870000},"page":"475-485","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":99,"title":["<scp>Long\u2010Term<\/scp>\n                    Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19 Subunit of Interleukin\u201023, Through Two\u2009Years: Results From a Phase\n                    <scp>III<\/scp>\n                    , Randomized,\n                    <scp>Double\u2010Blind<\/scp>\n                    ,\n                    <scp>Placebo\u2010Controlled<\/scp>\n                    Study Conducted in\n                    <scp>Biologic\u2010Naive<\/scp>\n                    Patients With Active Psoriatic Arthritis"],"prefix":"10.1002","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6462-4280","authenticated-orcid":false,"given":"Iain B.","family":"McInnes","sequence":"first","affiliation":[{"name":"University of Glasgow  Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Proton","family":"Rahman","sequence":"additional","affiliation":[{"name":"Memorial University of Newfoundland  St. Johns Newfoundland Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice B.","family":"Gottlieb","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine Mt. Sinai  New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Hsia","sequence":"additional","affiliation":[{"name":"Janssen Research &amp; Development Spring House, Pennsylvania, and University of Pennsylvania  Philadelphia Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa P.","family":"Kollmeier","sequence":"additional","affiliation":[{"name":"Janssen Research &amp; Development, LLC  San Diego California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xie L.","family":"Xu","sequence":"additional","affiliation":[{"name":"Janssen Research &amp; Development, LLC  San Diego California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusang","family":"Jiang","sequence":"additional","affiliation":[{"name":"Janssen Research &amp; Development  Spring House Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihong","family":"Sheng","sequence":"additional","affiliation":[{"name":"Janssen Research &amp; Development  Spring House Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Shawi","sequence":"additional","affiliation":[{"name":"Janssen Pharmaceutical Companies of Johnson &amp; Johnson  Horsham Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7957-838X","authenticated-orcid":false,"given":"Soumya D.","family":"Chakravarty","sequence":"additional","affiliation":[{"name":"Janssen Scientific Affairs Horsham, Pennsylvania, and Drexel University College of Medicine  Philadelphia Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9sir\u00e9e","family":"van der Heijde","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center  Leiden The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6620-0457","authenticated-orcid":false,"given":"Philip J.","family":"Mease","sequence":"additional","affiliation":[{"name":"Swedish Medical Center\/Providence St. Joseph Health and University of Washington  Seattle Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,2,7]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39573"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217159"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-04928-x"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.02.001"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02380-z"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-017-3593-x"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-019-04345-1"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.65"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.416"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-018-8702-3"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030451"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2009.01.003"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30830-4"},{"key":"e_1_2_8_15_1","unstructured":"Tremfya[package insert]. Horsham (PA): Janssen Biotech;2020."},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30265-8"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30263-4"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41553"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001457"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23568"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20967"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.030809"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2013.865009"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1159\/000250839"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199206000-00002"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380602"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200422001-00004"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.102053"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150826"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00347-5"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40391"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1782817"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-020-00555-7"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31773-8"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001679"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-eular.479"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.11.004"}],"container-title":["Arthritis &amp; Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.42010","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/art.42010","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.42010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T20:19:57Z","timestamp":1759954797000},"score":1,"resource":{"primary":{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/10.1002\/art.42010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,7]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1002\/art.42010"],"URL":"https:\/\/doi.org\/10.1002\/art.42010","archive":["Portico"],"relation":{},"ISSN":["2326-5191","2326-5205"],"issn-type":[{"value":"2326-5191","type":"print"},{"value":"2326-5205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,7]]},"assertion":[{"value":"2021-05-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}